Julie Gorham
Université libre de Bruxelles
17 Papers
24 Citations
Julie Gorham is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 13 publications. Previous affiliations of Julie Gorham include Institut Jules Bordet.
Chat about Author
Papers
The lung cancer patient at the emergency department: A three-year retrospective study
TL;DR: It is shown that emergency visit is a frequent event for lung cancer patients and has identified simple factors predicting hospitalisation and deaths.
33
Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection.
Anthony Moreau,Amédée Ego,Frederic Vandergheynst,Fabio Silvio Taccone,Niloufar Sadeghi,Isabel Montesinos,Nicolas Gaspard,Nicolas Gaspard,Julie Gorham +8 more
TL;DR: A case of neurological symptoms associated with cytotoxic lesions of the corpus callosum (CLOCCs) in a COVID-19 patient, the first description of which has been reported in several viral infections, is reported.
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.
Claudine Sculier,Georgiana Bentea,Lucien Ruelle,Bogdan Grigoriu,Michelle Coureau,Julie Gorham,Spyridon Sideris,Stéphane Holbrechts,Jean-Jacques Lafitte,Anne-Pascale Meert,Valérie Durieux,Thierry Berghmans,Jean-Paul Sculier +12 more
TL;DR: This article is the last of a series of five and deals mainly with onconeural antibodies involved in neurological paraneoplastic syndromes and provides the final discussion.
15
Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment
TL;DR: An overview of the basic principles of PK and pharmacodynamics of antibiotics and the main patient and pathogen characteristics that may affect the dosage ofiotics and different approaches to adjust doses is provided.
How to Use Nebulized Antibiotics in Severe Respiratory Infections
TL;DR: In this paper , the authors describe the current evidence on the use of nebulized antibiotics for the treatment of severe respiratory infections caused by multidrug-resistant (MDR) pathogens.